Today: 2 July 2026

Michał Rogucki

Michał Rogucki is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic developments. A graduate of Humboldt University of Berlin, he previously worked in investment research and market analysis before transitioning to financial journalism. He covers the trends and events that matter most to investors worldwide.

Korea Exchange Last Week: KOSPI Ends Down 11% After Record Crash, KOSDAQ Limits Damage

Korea Exchange Last Week: KOSPI Ends Down 11% After Record Crash, KOSDAQ Limits Damage

On Friday, South Korea’s KOSPI barely budged, finishing almost flat, though over the past week it still sank roughly 10.6% from Feb. 27—one of the sharpest drops in its history. The KOSDAQ, which tracks smaller tech and biotech names, closed the day at 1,154.67, eking out a gain for Friday but holding about 3.2% below where it stood a week ago. The swing hits hard here, with Seoul’s market barely over 6,000 after smashing through that barrier for the first time on Feb. 25, powered by chipmakers riding the artificial intelligence surge. Just a week ago, the rally looked relentless. Now, the KOSPI’s vulnerability to oil jumps and heavy foreign bets is hard to miss.
Australian Securities Exchange Weekly Wrap: ASX 200 Sheds A$130 Billion as Middle East War and Rate Risks Rattle Stocks

Australian Securities Exchange Weekly Wrap: ASX 200 Sheds A$130 Billion as Middle East War and Rate Risks Rattle Stocks

Australian stocks took a hard hit last week, with the S&P/ASX 200 tumbling 3.8% amid escalating concerns over the Middle East conflict. Investors saw around A$130 billion in value erased from the market. On Friday, the index sank another 1%, which wiped out close to half the gains made in February. The timing is critical, as the selloff comes up against a more hawkish domestic rates backdrop. Reserve Bank of Australia Governor Michele Bullock called March 17 a “live meeting,” just as new data revealed fourth-quarter GDP up 0.8% and annual growth at 2.6%—both quicker than anticipated.
FTSE 100 reels from worst week in a year as oil shock hits London stocks

FTSE 100 reels from worst week in a year as oil shock hits London stocks

London shares took their hardest weekly knock in nearly a year, rattled by climbing oil prices and more signs of strain in the U.S. economy that shook confidence at the London Stock Exchange. On Friday, the FTSE 100 shed 1.2%, while the mid-cap FTSE 250 dipped 0.8%. Both indexes just chalked up their roughest week since the sharp drop last April, when U.S. “Liberation Day” tariffs set off a global selloff, according to Reuters. This shift hit traders who’d been counting on rate cuts to prop up valuations, but the oil jump has thrown that calculus off. With energy prices rising, inflation risks get stickier—leaving central banks on edge, particularly in the UK, where fuel and household expenses spark political nerves.
Nifty’s worst week in over a year: what slammed India’s NSE stocks and the rupee

Nifty’s worst week in over a year: what slammed India’s NSE stocks and the rupee

Friday wrapped up a tough stretch for India’s National Stock Exchange, with the Nifty 50 sinking 2.9% for the week to 24,450.45, matching the Sensex, which also fell 2.9% and settled at 78,918.9. With the U.S.-Israeli conflict with Iran driving oil prices up and unsettling investors, the market took a hit. Still, Samrat Dasgupta of Esquire Capital called the selloff “a compelling window” to snap up stocks with “reasonable valuations.” Why it’s hitting now: oil’s the lever. Any spike in crude drops right into India’s import costs, stirring up fresh inflation fears well before quarterly results reflect the squeeze—and that’s what traders were reacting to. The mood soured everywhere: U.S. and European equities finished the week in the red as oil charged higher and investors absorbed a surprise miss in U.S. jobs numbers.
7 March 2026
Last Week on Shenzhen Stock Exchange: ChiNext Reform Push Fails to Halt Weekly Slide

Last Week on Shenzhen Stock Exchange: ChiNext Reform Push Fails to Halt Weekly Slide

SHENZHEN, March 7, 2026, 2:07 PM CST China announced Friday it’s rolling out fresh listing rules for Shenzhen’s ChiNext board, aiming to attract more innovative firms. Still, even with a small bounce that day, markets in the city wrapped up the week lower. The Shenzhen Component index added 0.59%, finishing at 14,172.63 on March 6. ChiNext, which focuses on high-growth names, climbed 0.38% to 3,229.30. Both benchmarks, though, closed out the week down—off 2.2% and 2.4% from the previous Friday.
7 March 2026
Mesoblast Limited shares rise as Ryoncil launch puts $120 million sales target in play

Mesoblast Limited shares rise as Ryoncil launch puts $120 million sales target in play

Mesoblast Limited climbed roughly 3% early Friday in U.S. trade, as investors zeroed in on the cell-therapy company following last week’s first-ever annual sales outlook for Ryoncil. Shares hovered around $16.20 as of 9:40 a.m. ET. Mesoblast is banking on a single greenlit product to validate its pipeline after years of R&D costs. The company’s Ryoncil, also known as remestemcel-L-rknd, just became the first mesenchymal stromal cell therapy to win FDA approval in the U.S. The treatment — derived from donor bone marrow — is now authorized for children as young as 2 months who aren’t helped by steroids for acute graft-versus-host disease.
6 March 2026
MakeMyTrip to Buy Flamingo Transworld Stake as India Holiday Package Travel Grows

MakeMyTrip to Buy Flamingo Transworld Stake as India Holiday Package Travel Grows

MakeMyTrip on Thursday announced an agreement to take a majority stake in Flamingo Transworld, a regional tour operator, marking another move into bundled holiday packages that combine hotels, transport, and sightseeing. No price was disclosed, and closing conditions still apply. This is a notable shift: hotels and packages now top the revenue charts for MakeMyTrip, and they’re expanding at a pace that’s leaving air ticketing behind. For the quarter ending Dec. 31, that division booked a 9.7% jump in revenue, reaching $161.4 million. Air ticketing, on the other hand, slid 2.1%. The company blamed it on tight domestic airline supply and a softer rupee.
6 March 2026
Sea shares whipsaw again after Shopee growth target sparks a spending worry

Sea shares whipsaw again after Shopee growth target sparks a spending worry

Sea Ltd slipped roughly 2% Friday morning in New York, paring some of Thursday’s 8.2% pop as the market digested the company’s intentions for increased spending. Shares traded at $93.53, down 2.1% as of 9:43 a.m. ET. https://stockanalysis.com/stocks/se/history/ The shift is significant: Sea’s been under pressure to show Shopee, its main revenue driver, can expand without margins unraveling again. The company’s performance is watched closely as a gauge for Southeast Asian e-commerce and digital lending, sectors known for fast-moving price battles and shifting promos.
Netskope Inc rolls out AI Guardrails ahead of March 11 earnings as enterprise AI security race heats up

Netskope Inc rolls out AI Guardrails ahead of March 11 earnings as enterprise AI security race heats up

SANTA CLARA, Calif., March 6, 2026, 06:25 PST Netskope this week announced that AI Guardrails, its tool designed to give employers greater oversight on how staff interact with generative AI, is now out of preview and fully available. The general release lands just ahead of the cybersecurity group’s March 11 AI launch event, which coincides with its fourth-quarter earnings.
Ecopetrol May Raise 2026 Spending as Oil Rally Revives Venezuela Push

Ecopetrol May Raise 2026 Spending as Oil Rally Revives Venezuela Push

Ecopetrol could revisit its 2026 investment plan as early as April if elevated oil prices persist. The Colombian state oil giant is also pushing to secure access for deals in Venezuela. For now, executives see spending coming in toward the upper end of the 22 trillion to 27 trillion peso guidance. Timing’s key here. Brent’s surged roughly 24% this week to near $90 a barrel, after the Iran conflict threw off shipments through the Strait of Hormuz. That’s the sort of price spike that can upend cash flow forecasts for an oil producer working off a budget set last November.
Okta Stock Jumps After Q4 Beat, but Slowest Growth Forecast Since IPO Still Looms

Okta Stock Jumps After Q4 Beat, but Slowest Growth Forecast Since IPO Still Looms

Okta posted stronger-than-expected revenue and earnings, with the stock climbing $7.99 to $79.65 following the report. The company pointed to demand driven by fresh product offerings. Still, Okta kept its revenue growth outlook at 9% for the current quarter—the slowest since its IPO in 2017. The split’s become important. Investors are weighing whether Okta’s newer AI-driven identity products and focus on bigger enterprise clients can actually reignite momentum, or if cautious software spending will leave growth hovering in the single digits. Management projected 9% revenue growth for both the April quarter and fiscal 2027, sticking with a cautious stance on the broader market.
UniFirst Corporation Stock Jumps After Report Says Cintas Is Nearing a Deal Above $275 a Share

UniFirst Corporation Stock Jumps After Report Says Cintas Is Nearing a Deal Above $275 a Share

Cintas is closing in on a deal to acquire workwear rival UniFirst, according to Bloomberg Law, which reported Thursday that negotiations are ongoing over a price tag north of $275 per share—or about $5.2 billion—the same offer Cintas put forward in December. UniFirst shares jumped 13.6% in premarket action Friday. This report brings fresh momentum to a deal that hit pause back on March 24, 2025. That’s when Cintas CEO Todd Schneider said negotiations with UniFirst had failed to move forward on crucial terms. UniFirst, for its part, had noted on Dec. 22 that its board was still weighing Cintas’ non-binding proposal with help from external advisers.
Rentokil shares jump as profit rises, chair exit plan and termite provision land

Rentokil shares jump as profit rises, chair exit plan and termite provision land

Rentokil Initial plc reported a 4% gain in adjusted pretax profit for 2025 on Thursday, crediting stronger performance in North America during the latter half of the year. The company also announced an upcoming board leadership change. Shares surged over 10% in London after the news. North America remains under the microscope after the Terminix acquisition, especially with a leadership change looming this month. The question for investors: can tweaks to marketing, branch ops, and IT turn the growth dial without crimping margins?
6 March 2026
Robinhood Markets cuts RVI IPO size as premium card push targets wealthier investors

Robinhood Markets cuts RVI IPO size as premium card push targets wealthier investors

Robinhood Markets priced the initial public offering of its first private-markets fund, Robinhood Ventures Fund I, at 12,615,608 shares at $25 apiece on Friday, well below the 40 million-share plan it outlined when the roadshow began last month. Robinhood said the deal would give RVI a total fund size of $658.4 million, or up to $705.7 million if the underwriter’s option is exercised in full. The smaller deal lands as Robinhood tries to broaden its business beyond trading and crypto activity. The company posted record quarterly revenue in February but still missed Wall Street estimates after slower crypto trading, and this week rolled out new family-finance products alongside its latest card push.
Tango Therapeutics stock jumps 36% after Q4 results, Erasca cancer trial pact

Tango Therapeutics stock jumps 36% after Q4 results, Erasca cancer trial pact

Tango Therapeutics surged about 36% Thursday, propelled by fourth-quarter numbers and news of a fresh partnership with Erasca to study vopimetostat—the company’s lead drug—in pancreatic and lung cancer settings. Shares recently changed hands at $16.83. The update is significant for Tango, which has its sights set on advancing vopimetostat—a PRMT5 inhibitor targeting a cancer-linked enzyme—out of early-phase trials and into a pivotal study, the usual step toward seeking approval. Tango still plans to kick off the second-line pancreatic cancer trial in 2026, after initial treatment, and says first phase 1/2 combination data should arrive before year's end.
Kenvue exec stock grants land as Kimberly-Clark deal drags on

Kenvue exec stock grants land as Kimberly-Clark deal drags on

Kenvue has handed out new stock-based awards to top execs, filings show this week. Among them: a block of 122,286 restricted stock units for the general counsel. The consumer health outfit is still awaiting regulatory go-aheads for its planned sale to Kimberly-Clark. The filings take on extra weight as Kenvue navigates a lengthy, very public run-up to a change of control. During this stretch, investors and employees are watching retention, pay, and leadership stability with sharper focus than usual.
Vale denies it’s planning a Base Metals IPO after Brazil regulator queries CEO comments

Vale denies it’s planning a Base Metals IPO after Brazil regulator queries CEO comments

Vale clarified it isn’t conducting any studies or has taken any management decision on a possible share sale of its Vale Base Metals arm. The statement comes after Brazil’s securities regulator and the B3 exchange pressed the company to address media reports linked to remarks by Vale Base Metals CEO Shaun Usmar. According to a letter from the regulator, Usmar told BNN Bloomberg Television the unit’s goal was “to prepare the company for an IPO for our shareholders … around mid-year.” This pushback is significant: Vale Base Metals represents the group’s core growth story beyond iron ore. Any plan to list it would alter how investors assign value to the business—and impact how future projects get financed.
6 March 2026
Nu Holdings lands Inter Miami stadium naming rights in latest U.S. branding push

Nu Holdings lands Inter Miami stadium naming rights in latest U.S. branding push

Nu Holdings Ltd, operator of Brazil’s Nubank, has landed a multiyear deal with Inter Miami CF for naming rights at the soccer club’s new Miami stadium, the company announced Wednesday. The move marks Nu’s bid to boost its U.S. visibility. Cristina Junqueira of Nu described the partnership as an “anchor” for their brand stateside. Inter Miami’s managing owner Jorge Mas said the club sought out partners sharing a “disruptor mindset.” This deal stands out right now as Nu shifts gears in Latin America, leaving its fast-growth streak behind and facing a harder challenge: convincing existing customers to buy more, while dipping its toes into new markets. Slapping its brand on a stadium—a classic naming-rights move—may seem a broad-brush approach, but getting that logo in front of American audiences could quickly boost recognition for a still unfamiliar name.
6 March 2026
1 15 16 17 18 19 42

Stock Market Today

  • ASX Seen Lower as Oil Falls on US-Iran Talks; Northern Star Resources Holds to Gold Sales Goal
    July 1, 2026, 9:04 PM EDT. Australian stocks look set to open down Thursday with oil slipping over 1% to the lowest since March after progress in US-Iran talks eased concerns over supply. Northern Star Resources kept its fiscal 2026 gold sales target, giving the mining sector a steadier footing while the broader market weakens. Investors remain cautious, watching commodity moves as geopolitical headlines hit sentiment.
Go toTop